INTRODUCTION
Survival of Mycobacterium tuberculosis within the host macrophage is dependent on the basic structure of lipomannan (LM) and lipoarabinomannan (LAM) [1, 2] . LAM belongs to the class of bacterial factors termed modulins and operates by inducing the expression of several ' early ' genes, which are involved in macrophage activation [3] , synthesis of host cytokines such as tumour necrosis factor-α [4] and production of nitric oxide, synergistically with interferon-γ [5] . LAM is also implicated in the phagocytosis of mycobacteria by phagocytic cells [6] . Phosphatidyl-myo-inositol mannosides (PIMs), known to be precursors of LM and LAM, have been recently proposed to recruit natural killer T cells, which play a primary role in the granulomatous response [7, 8] .
Although the structure of LAM has been well documented [2, 9, 10] , the genetics of its biosynthesis still remains largely illdefined. It involves the addition of mannose (Man) residues to phosphatidyl-myo-inositol to produce both the short PIMs (2-5 Man residues) and LM, which is further glycosylated with arabinan to form LAM. The biosynthetic relationship of phosphatidyl-myo-inositol PIMs LM LAM has recently been supported by biochemical [11, 12] and genetic studies [13] . Besra et al. [12] demonstrated that triacylated PIM # (phosphatidylmyo-inositol dimannoside) is specifically extended by the addition of Manp residues from the alkali-stable sugar donor, polyprenol
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such as M. smegmatis, M. a ium and M. leprae produce two distinct proteins, which are similar to the two domains found in Mt-Ppm1. Using an in itro assay, we also demonstrate that MtPpm1 transfers Man from GDP-Man to a structurally diverse range of lipid monophosphate acceptors. The identification of the PPM synthase as a key enzyme in lipoarabinomannan biosynthesis now provides an attractive candidate for gene disruption to generate mutants for subsequent immunological studies. PPM synthase can also be exploited as a target for specific inhibitors of M. tuberculosis.
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monophosphomannose (PPM), to form higher PIMs (at least triacylated PIM $ and PIM % ) and linear LM. PPM is generated from GDP-Man and the corresponding polyprenol phosphate. Therefore the PPM synthase is a key enzyme in the generation of PPM, which is subsequently utilized in the biosynthesis of LM and LAM.
As an approach to studying the biosynthesis and immunological function of various mannan-containing glycoconjugates (LM and LAM) in mycobacteria, we have exploited the recently available M. tuberculosis genome sequence [14] . By comparison with a variety of published eukaryotic dolichol monophosphomannose (DPM) synthase sequences, we identified a homologous synthase in M. tuberculosis, now termed as Mt-Ppm1. Surprisingly, the protein identified is much larger than the eukaryotic or bacterial homologues and is composed of two domains. The catalytic DPM-homologous domain is located in the C-terminus of the protein, whereas the N-terminal domain possesses a low degree of similarity with a variety of bacterial acyltransferases. Interestingly, related mycobacterial species such as M. leprae, M. a ium and M. smegmatis possess the equivalent locus, but it is organized as an operon with two distinct genes encoding proteins that display a high degree of sequence similarities to the C-and N-domains of Mt-Ppm1. The identification of the PPM synthase as a key enzyme in LAM biosynthesis now provides an interesting target to be exploited, possibly in the generation of LAMdeficient mutants for subsequent immunological studies, or alternatively for the validation of the mycobacterial PPM synthase as a possible drug target.
EXPERIMENTAL Bacterial strains and growth conditions
All cloning steps were performed in Escherichia coli XL1-Blue (Stratagene, La Jolla, CA, U.S.A.). M. smegmatis mc#155 was a gift from W. R. Jacobs (Albert Einstein College of Medicine, Bronx, New York, U.S.A.) [15] . M. smegmatis mc#155 was transformed as described previously [16] , and recombinant clones were selected on Middlebrook 7H10 agar supplemented with oleic acid\albumin\dextrose\catalase enrichment (Difco, Detroit, MI, U.S.A.) containing 25 µg\ml kanamycin (Sigma). Liquid cultures of M. smegmatis (pMV261) and M. smegmatis (pMV261-Mt-ppm1) [also M. smegmatis (pMV261-Mt-ppm1\ D1) and M. smegmatis (pMV261-Mt-ppm1\D2)] were grown at 37 mC in Luria-Bertani broth (Difco) supplemented with 25 µg\ ml kanamycin and 0.05 % (v\v) Tween 80. Liquid cultures of E. coli (pUC8) and E. coli (pUC8-Mt-ppm1\D2) were grown in Luria-Bertani broth at 37 mC with 100 µg\ml ampicillin to A '!! 0.4 and induced for 4 h with 1 mM isopropyl β--thiogalactopyranose. Large-scale cultures of bacteria were grown as described above, harvested by centrifugation, washed with PBS and stored at k20 mC until further use.
Plasmids and DNA manipulation
The E. coli-mycobacterial shuttle vector pMV261, containing the hsp60 promoter, was used as described previously [17] . With the electroduction of E. coli as described in [18] , analysis of plasmids from mycobacteria was achieved. Restriction enzymes and T4 DNA ligase were purchased from Boehringer Mannheim (Mannheim, Germany) and Vent DNA polymerase was purchased from New England Biolabs (Beverly, MA, U.S.A.). The manipulations of all DNA were performed using standard protocols.
Cloning of Mt-ppm1, Mt-ppm1/D1 and Mt-ppm1/D2
Sequences for R 2051c (Mt-ppm1) and the sequences corresponding to the N-and C-terminal domains of the R 2051c gene product (Mt-ppm1\D1 and Mt-ppm\D2 respectively), required for cloning into pUC8 [19] and\or pMV261 [17] , were obtained by PCR using Vent polymerase (New England Biolabs). The complete R 2051c DNA fragment was amplified using the primer pairs 145 and 146. The 2740 bp PCR product was then digested with EcoRI and cloned into EcoRI-MscI-restricted pMV261, giving rise to pMV261-Mt-ppm1. Mt-ppm1\D1 and Mt-ppm1\ D2 were generated by PCR using pMV261-Mt-ppm1. Mtppm1\D1 was amplified using primer pairs 146 and 152, whereas Mt-ppm1\D2 was amplified using primer pairs 134 and 135. After restriction with EcoRI, the fragments were cloned into pMV261, previously digested with MscI-EcoRI to create pMV261-Mt-ppm1\D1 and pMV261-Mt-ppm1\D2 respectively. For expression in E. coli, Mt-ppm1\D2 was cloned into pUC8 cut by SmaI generating pUC8-Mt-ppm1\D2. The DNA of each construct was sequenced to verify the coding sequence of Mtppm1 (also Mt-ppm1\D1 and Mt-ppm1\D2) as well as its junction with the hsp60 or Plac promoters. Oligonucleotides : no. 145 : 5h-ACCGAATTCGAGGACGACCTGCCCGAGCC-3h ; no. 146 : 5h-TGAAGCTTGGCGCATGGGTGGCAGC-3h ; no. 152 : 5h-GGGAATTCTGGCTGGGACGGTTACC-3h ; no. 134 : 5h-GGAATTCCGGTCGTGCGCGTGCGTGGTC-3h ; no. 135 : 5h-GGAATTCGCCTCGAGCTCATTCGGTCACG-3h.
Cloning and sequencing of the M. smegmatis ppm1 locus
The DNA sequence encoding the orthologue of Ppm1 in M. smegmatis (Ms-Ppm1) was identified from a genomic cosmid library by colony-blot hybridization. The cosmid library referred as pYUB415 : : 155 has been described by Yu et al. [20] and was provided by W. R. Jacobs (Albert Einstein College of Medicine, New York, NY, U.S.A.). The library was used to transform E. coli TOP-10 cells (Invitrogen). For isolation of Ms-ppm1, approx. 600 individual clones were screened with the labelled 3h-end of Mt-ppm1. The probe was labelled with digoxigenin (DIG)-dUTP5h using the PCR DIG Probe Synthesis Kit (Boehringer Mannheim) with the following specific oligonuceotides : no. 174 : 5h-GGAATTCGCCTCGAGCTCATTCGGTCACG3h ; no. 175 : 5h-CCACAGGACAGCCGGCGCCCCCAGC-3h.
Prehybridization, hybridization, post-hybridization washes and detection were performed according to the manufacturer's recommendations. From four positive clones, cosmid DNA was prepared and further analysed by restriction digests and Southern-blot hybridization. BamHI restriction of one of these cosmids produced a 5-kb fragment reacting strongly with the probe by Southern-blot hybridization. This fragment was subsequently purified, cloned into pUC18 and analysed by DNA sequencing.
Preparation of enzyme fractions
and E. coli (pUC8-Mt-ppm1\D2) were grown as described above, harvested by centrifugation, washed with PBS and stored at k20 mC until further use. Mycobacterial cells (10 g wet wt) were washed and resuspended in 30 ml of buffer A, containing 50 mM Mops (adjusted to pH 8.0 with KOH), 5 mM β-mercaptoethanol and 10 mM MgCl # at 4 mC and subjected to sonication (1 cm probe ; Soniprep 150, MSE Sanyo Gallenkamp, Crawley, Sussex, U.K.) for a total time of 10 min using 60 s pulses and 90 s cooling intervals. E. coli cells were disrupted in a similar way using 30 s pulses and 45 s cooling intervals. The sonicated materials were centrifuged at 27 000 g for 60 min at 4 mC. The supernatant fractions from E. coli (pUC8) or E. coli (pUC8-Mt-ppm1\D2) were used in all subsequent PPM experiments. Membrane fractions from M. smegmatis harbouring pMV261, pMV261-Mt-ppm1, pMV261-Mtppm1\D1 or pMV261-Mt-ppm1\D2 were obtained by further centrifugation of the 27 000 g supernatant at 100 000 g for 1 h at 4 mC. The supernatant was carefully removed and the membranes were gently resuspended in buffer A at a protein concentration of 20 mg\ml. Protein concentrations were determined using the BCA Protein Assay Reagent kit (Pierce Europe, Oud-Beijerland, The Netherlands).
PPM synthase assay
Reaction mixtures for assessing ["%C]Man incorporation consisted of 2.4 µM GDP-[U-"%C]Man (321 mCi\mmol, 0.25 µCi ; DuPont-New England Nuclear), 62.5 µM ATP, 10 µM MgCl # and membrane preparations corresponding to 5-25 µg protein in a final vol. of 50 µl. In some cases, exogenous lipid monophosphate [32] The gene products shown are from M. tuberculosis H37Rv (Ppm1-Mt ), H. influenzae (Lnt-Hi ), E. coli (Lnt-Ec ), Streptomyces coelicolor A3 (Lnt-Stc ), human (Dpm1-hu ) and S. cerevisiae (Dpm1-Sac ). Conserved (black) or related (grey) residues are boxed. The two domains of Mt-Ppm1 (Mt-Ppm1/D1 and Mt-Ppm1/D2) are shown separately with their respective homologues. The arrow indicates the conserved serine residue proposed to be phosphorylated in eukaryotic DPM synthases [33] .
were added to the reaction mixtures at a final concentration of 0.25 mM in 0.25 % (v\v) CHAPS. The reaction mixtures were then incubated at 37 mC for 30 min.
Extraction and characterization of [ 14 C]Man-labelled products from reaction mixtures
The enzymic reactions were terminated by the addition of CHCl $ \CH $ OH\0.8 M NaOH (10 : 10 : 3, by vol.) (4 ml\50 µl of reaction mixture) followed by further incubation at 50 mC for 20 min. The mixtures were then allowed to cool ; 1.75 ml of CHCl $ and 0.75 ml of water were added. The mixture was vortexed and centrifuged, and the upper aqueous phase discarded. The organic phase was washed three times with 2 ml of CHCl $ \ CH $ OH\H # O (3 : 47 : 48, by vol.), dried to yield an organic fraction, which contained exclusively the mild-alkali stable family of PPMs or DPMs. Alternatively, after base treatment, the reaction mixtures possessing exogenous substrates C "! and C "& monophosphates were dried and partitioned between the phases arising from butan-1-ol and water. The butan-1-ol-saturated water layer was recovered, backwashed twice with water saturated with butan-1-ol and dried. The resulting PPMs and DPMs were resuspended in 200 µl of either CHCl
and an aliquot (20 µl) was dried under a stream of argon in a scintillation vial before scintillation counting using 10 ml of Ecolume TM (ICN Biomedicals, Costa Mesa, CA, U.S.A.). TLC of the reaction products, usually aliquots representing 10 % of the reaction mixtures, was conducted on aluminium-backed plates of silica gel 60 F #&% (E. Merck, Darmstadt, Germany) using CHCl $ \ CH $ OH\NH % OH\H # O (65 : 25 : 0.4 : 3.6, by vol.). Autoradiograms were obtained by exposing chromatograms to Kodak X-Omat AR films at k70 mC for 4-5 days. Large-scale reaction mixtures containing unlabelled GDP-Man (80 mM) and the other components were prepared and processed as described above. The chemical identity of mycobacterial PPMs was confirmed following preparative TLC [12] and analytical electrospray ionization MS (Quattro II triple quadrupole mass spectrometer ; Micromass, Beverly, MA, U.S.A.). Electrospray MS was also performed on crude reaction products resulting from the utilization of exogenous polyprenol and dolichol monophosphate substrates and on enzymic extracts prepared from E. coli (pUC8-Mt-ppm1\D2).
RESULTS

Identification of Mt-ppm1
In eubacteria, biosynthetic lipid intermediates based on polyprenols are usually involved in peptidoglycan and O-antigen biosynthesis and are generally of the polyprenol-pyrophosphateoligosaccharide type [21] . By contrast, mycobacterial polyprenol phosphates used as carriers during LAM biosynthesis contain single Man residues linked to the lipid prenol moiety through a monophosphate group [12] . Since similar carriers, such as DPM, are found in eukaryotes, we have used the amino-acid sequences of various DPM synthases to blast the M. tuberculosis H37Rv genome database. One strong match was found for the mycobacterial gene R 2051c. As polyprenol phosphates, and not dolichol phosphates, are the acceptors of Man from GDP-Man in mycobacteria, we named the gene Mt-ppm1. Interestingly, only the C-terminal region of the predicted Mt-Ppm1 protein is similar to the human Dpm1 (Figure 1 ). The N-terminal domain of Mt-Ppm1 shows some similarities to various putative apolipoprotein N-acyltransferases (Lnt). A computer-assisted analysis revealed several putative transmembrane regions in this domain of Mt-Ppm1 (Figure 2 ). In addition, the presence of a predicted transmembrane α-helix, followed by a stretch of prolines at the hinge of the two domains, suggests that these two regions of the protein are located on opposite sites of the membrane (Figure 2) . Thus based on similarity and hydrophobicity profiles, we postulated that the catalytic domain of Mt-Ppm1 is located in the second domain. These analyses also suggested that the two domains of the proteins could be artificially disconnected and studied separately. Hence, in addition to the complete Mt-ppm1 open reading frame, two regions coding for the putative MtPpm1 domains, Met"-Tyr&*$ and Met&*%-Glu)(%, were amplified by PCR and cloned in frame with the initiation codon of hsp60 into pMV261 to yield pMV261-Mt-ppm1, pMV261-Mt-ppm1\ D1 and pMV261-Mt-ppm1\D2. Also, Mt-ppm1\D2 was fused to lacZ in pUC8 for expression in E. coli.
Incorporation of GDP-[ 14 C]Man by enzymic extracts from M. smegmatis (pMV261-Mt-ppm1), (pMV261-Mt-ppm1/D2) and E. coli (pUC8-Mt-ppm1/D2)
To establish the relationship between R 2051c and PPM synthesis, we examined extracts prepared from bacteria expressing Mt-ppm1 and\or Mt-ppm1\D2. M. smegmatis and E. coli were transformed with plasmids pMV261-Mt-ppm1\D2 and pUC8-Mt-ppm1\D2 respectively to overproduce the putative catalytic domain Mt-Ppm1\D2. The relative PPM transferase activities within these preparations were compared with those of extracts prepared from M. smegmatis and E. coli transformed with pMV261 and pUC8 respectively ( Table 1 ). The PPM synthase activity from M. smegmatis (pMV261-Mt-ppm1\D2) membrane extracts was significantly increased compared with that of M. smegmatis (pMV261) membrane extracts ( Table 1 ). E. coli (pUC8) was found to possess no PPM transferase activity in the presence of exogenous C &! -polyprenol monophosphate lipid substrate. However, E. coli overexpressing Mt-ppm1\D2 possessed considerable PPM transferase activity using exogenous C &! -polyprenol monophosphate lipid as substrate ( Table 1 ), confirming that R 2051c encodes a PPM synthase and that the GDP-Man : polyprenol phosphate mannosyltransferase activity is catalysed by the second domain of the protein.
To evaluate the possible role of domain 1 of Mt-Ppm1, enzymic assays were performed with membrane fractions (5 µg each) prepared from M. smegmatis harbouring pMV261, pMV261-Mt-ppm1 and pMV261-Mt-ppm1\D2. Membranes prepared from M. smegmatis pMV261-Mt-ppm1 in several independent experiments consistently catalysed a 3-fold higher PPM production (7.48p0.29 pmol\min) compared with membrane fractions prepared from M. smegmatis (pMV261-Mtppm1\D2) (2.34p0.09 pmol\min) and an approx. 5-fold higher activity compared with membrane fractions prepared from M. smegmatis (pMV261) (1.46p0.08 pmol\min). Values are given as meanspS.E.M. (Figure 3) . These results suggest either that full-length Ppm1 and\or its mRNA is more stable than Ppm1\D2 and\or its mRNA, or that domain 1 exerts a positive influence on the catalytic activity of domain 2. Quantification of PPM synthesis in extracts prepared from E. coli, harbouring both Mtppm1\D1 and Mt-ppm1\D2 on compatible plasmids, would allow discrimination between these two possibilities. Unfortunately, several attempts to express Mt-ppm1\D1 (or Mt-ppm1) in E. coli failed (results not shown). This observation and the earlier prediction of several putative transmembrane regions in domain 1 (Figure 2 ) suggest that production of Mt-Ppm1\D1 can be toxic for E. coli. We therefore decided to turn to a mycobacterial expression system.
Identification of the M. smegmatis PPM locus and role of Mt-ppm1-D1 in M. smegmatis PPM synthase activity
M. a ium and M. leprae potentially produce two distinct proteins, which are similar to the two domains found in Mt-Ppm1 respectively. The sequence and structure of the homologous ppm1 locus of M. smegmatis was examined. Sequence analysis of the locus revealed that the homologue of Mt-ppm1 is encoded by two separate and adjacent genes, one of 1785 nt (gene homologous with Mt-ppm1\D1, now termed Ms-ppm2) and one of 797 nt (gene homologous with Mt-ppm1\D2, now termed Msppm1) respectively (GenBank2 Nucleotide Sequence Database accession no. AJ294477). An intergenic region of 9 nt containing a putative ribosome-binding site separates the two genes ( Figure 4) .
To evaluate the possible role of Mt-Ppm1\D1 on PPM synthase activity in M. smegmatis, membrane fractions (5 µg each) were prepared from M. smegmatis (pMV261-Mt-ppm1\ D1) and were found to consistently increase PPM synthesis (2.31p0.08 pmol\min) in several independent experiments compared with membrane fractions prepared from M. smegmatis (pMV261) (1.46p0.08 pmol\min). Values are given as meansp S.E.M. This activity was similar to that expressed by M. smegmatis (pMV261-Mt-ppm1\D2) (2.34p0.09 pmol\min). In the light of the structure of the M. smegmatis ppm2-ppm1 locus (see Figure 4) , the above biochemical experiments suggest a possible role of Mt-Ppm1\D1 in PPM synthesis at a protein level. In addition, these results suggest that domains 1 and 2 do not need to be produced as a single protein, even if both are involved in PPM synthesis.
Identification and characterization of a novel C 40 -PPM from M. smegmatis
An examination of the mycobacterial PPM family by TLC\ autoradiography (Figure 3 ) indicated that all members of the mycobacterial PPM family were overproduced in M. smegmatis harbouring pMV261-Mt-ppm1, pMV261-Mt-ppm1\D2 or pMV261-Mt-ppm1\D1 (results not shown). This result suggests that the intact Ppm1 or the truncated versions are unable to discriminate between subtle chain-length variations found within the endogenous pool of polyprenol monophosphates. It is well documented that the major PPM in M. smegmatis is a C &! -PPM [22] , and our earlier studies [12] along with others [23] have identified a novel C $& -PPM in which four of the possible seven isoprenoid double bonds were saturated [23, 24] . The presence of a third, previously unknown member of the PPM family was surprising and probably reflects the improved TLC resolution in the present study, compared with previous studies [22] [23] [24] . Electrospray MS of the individual PPMs generated from unlabelled GDP-Man after preparative TLC purification [12, 24] Figures 3A and 3C ). An intense (MkH) − ion was also obtained at m\z l 811, M r 812, which corresponds to the addition of a C & -isoprene (m\z l 68) to the mycobacterial C $& -PPM, suggesting that the unknown PPM is a C %! -PPM that is structurally related to the mycobacterial C $& -PPM (see Figure 3B ) [24] . 
Table 2 Incorporation of [ 14 C]Man from GDP-[ 14 C]Man and exogenous polyprenol and dolichol monophosphates using enzymic extracts prepared from M. smegmatis (pMV261-Mt-ppm1/D2 ) [I] and E. coli (pUC8-Mtppm1/D2 ) [II]
The reaction mixtures contained various lipid monophosphate substrates at a final concentration of 0.25 mM in 0.25 % (w/v) CHAPS, membranes (25 µg) from M. smegmatis (pMV261-Mtppm1/D2 ) or enzymic extracts (5 µg) from E. coli (pUC8-Mt-ppm1/D2 ) in a total vol. of 50 µg. Incubations were performed for 30 min at 37 mC and the PPMs/DPMs isolated after base treatment before scintillation counting. The results represent means of duplicates. 
Incorporation of GDP-[ 14 C]Man by membrane fractions from M. smegmatis (pMV261-Mt-ppm1/D2) and enzymic extracts from E. coli (pUC8-Mt-ppm1/D2) using various lipid monophosphate substrates
The chain-length specificity of Mt-Ppm1\D2 in relation to other non-mycobacterial monophosphate isoprene lipid substrates was examined by the use of commercially available polyprenol\ dolichol monophosphates and membrane fractions from M. smegmatis (pMV261-Mt-ppm1\D2) or extracts from E. coli (pUC8-Mt-ppm1\D2). Incubation of membrane fractions from M. smegmatis (pMV261-Mt-ppm1\D2) in the absence of exogenous substrates led to a typical profile of (Table 2 ; Figure 5A, lane 10) . The E. coli (pUC8-Mtppm1\D2) extract expressed a moderate level of activity in the absence of substrate (Table 2) , which by TLC\autoradiography ( Figure 5B , lane 10) was attributed to the utilization of the endogenous E. coli C && -PPM pool. A similar observation by Orlean et al. [25] using recombinant yeast Dpm1 produced in E. coli suggested a lack of specificity with this family of glycosyltransferases. Interestingly, untransformed E. coli possessed no enzymic activity, a somewhat surprising observation given that alignment algorithms indicated the presence of an orthologue to Mt-Ppm1\D2 in the E. coli genome (P77757). Thus the putative E. coli gene may be inactive or may possess an unexpected substrate requirement, which is yet to be identified. C "! -geranyl monophosphate was inactive as a substrate for extracts from either M. smegmatis (pMV261-Mt-ppm1\D2) or E. coli (pUC8-Mt-ppm1\D2) and showed a slight inhibitory effect (Table 2 ; Figures 5A and 5B, lane 1). C "& -farnesyl monophosphate was weakly active. Increasing levels of PPM synthesis in place of endogenous PPM synthesis were observed with increasing chain lengths of the lipid monophosphate substrates (Table 2 ; Figures  5A and 5B, lanes 2-9) . The newly synthesized products, resulting from the incubation of the lipid substrates (C $& -C *& monophosphate), unlabelled GDP-Man and E. coli (pUC8-Mt-ppm1\D2) extracts, were further characterized using electrospray MS. The reaction products yielded intense (MkH) − ions for the precursor lipid phosphates and, more importantly, the addition of m\z 162 of a hexose unit (Man), confirming glycosylation of the lipid phosphates (see Figures 6A-6F ). Thus Mt-Ppm1\D2 seems to prefer substrates C "& and tolerates additional changes in the lipid moiety, such as saturation of the first isoprene unit for both the synthetic C $& -dolichol monophosphate and the C *& -dolichol monophosphate isolated from human livers. In addition to the saturation of the α-isoprene, other modifications such as the polysaturation of the mycobacterial C $& -and C %! -polyprenol monophosphates are also tolerated by the Mt-Ppm1\D2 synthase, suggesting that chain length is possibly the only key
Figure 5 Incorporation of [ 14 C]Man from GDP-[ 14 C]Man into exogenous polyprenol and dolichol monophosphates using extracts from M. smegmatis (pMV261-Mt-ppm1/D2 ) and E. coli (pUC8-Mt-ppm1/D2 )
The standard reaction mixture contained the indicated lipid monophosphate substrates at a final concentration of 0.25 mM in 0.25 % (w/v) CHAPS. Incubations were performed for 30 min at 37 mC with extracts from M. smegmatis (pMV261-Mt-ppm1/D2 ) (A) or E. coli (pUC8-Mt-ppm1/D2 ) (B), and the PPMs/DPMs were isolated after base treatment. An aliquot (10 %) was subjected to scintillation counting (see Table 2 ). A second aliquot (10 %) was subjected to TLC and autoradiography using CHCl 3 /CH 3 OH/NH 4 feature regarding the specificity of the mycobacterial PPM synthase.
DISCUSSION
Over the last decade, several studies have emphasized the role of LAM as a key factor in the major steps of tuberculosis immunopathogenesis and, paradoxically, also in protective immunity. Despite the importance of this immunomodulator, the biosynthetic origin of these important lipoglycans has largely been ignored until recently. The biosynthesis of PIMs is initiated by distinct α-mannosyltransferase activities that utilize GDP-Man as a sugar donor, transferring initially a Manp residue to the 2-position of myo-inositol to form phosphatidyl-myo-inositol monomannoside (PIM " ), followed by a further addition at the 6-position of myo-inositol to generate PIM # [11] . The latter α-mannosyltransferase activity has been shown to be catalysed by the pimB gene product from M. tuberculosis [13] . The addition of Manp residues to PIM # to form more complex PIMs also requires GDP-Man, according to the earlier studies of Brennan and Ballou [26] . However, Besra et al. [12] demonstrated that triacylated-PIM # is specifically extended by the addition of Manp residues from the alkali-stable sugar donor, PPM (C $& -and C &! -P-Man), which is generated from GDP-Man and the corre- As the enzymes in these biochemical steps have not been identified yet, we have embarked on a series of studies to identify mannosyltransferases implicated in the biosynthesis of LAM. The present communication reports on the identification of a PPM synthase from M. tuberculosis. Unexpectedly, Mt-Ppm1 turns out to be a two-domain enzyme. Mt-Ppm1\D2 is responsible for the catalytic activity of Mt-Ppm1 and Mt-Ppm1\D1 enhances the transferase activity of the protein by a mechanism that still needs to be clarified. Surprisingly, the Ppm1 orthologues in M. leprae, M. smegmatis and M. a ium do not show this two-domain architecture. Instead, two separate proteins are coded by neighbouring genes (Figure 4 ). It is highly probable that Mt-Ppm1 is the consequence of a recent genetic fusion between the ancestors of Mt-ppm1\D1 and Mt-ppm1\D2. The conservation of ppm1 genes in mycobacteria, especially in the highly reduced genome of M. leprae [27] suggests that PPM synthase is an essential enzyme in mycobacteria. The results obtained in M. smegmatis suggest that Mt-Ppm1\D1 could physically interact with Ms-Ppm1. The formal demonstration of the interaction between Mt-Ppm1\D1 and Ms-Ppm1, and by analogy between Ms-Ppm2 and Ms-Ppm1 is currently being investigated.
Based on the existence of two structurally distinct mycobacterial PPMs, Wolucka and de Hoffmann [28] proposed that specific mannosyltransferases would utilize individual polyprenol monophosphates. The rationale was based on the precedence that eukaryotic systems are able to differentiate between polyprenol substrates in terms of chain length and the presence of the α-saturated isoprene subunit. By contrast, the present study demonstrates that Mt-Ppm1 catalyses the production of three PPM species (C $& -, C %! -and C &! -PPM), and that Mt-Ppm1 synthase does not discriminate between polyprenol substrates in terms of chain length (for the endogenous polyprenol pool) and the nature of the saturated-isoprene subunits.
Eukaryotic DPM synthases have been classified into two families. Similar to the human synthase, Mt-Ppm1 lacks the typical C-terminal hydrophobic domain found in Dpm1 from Saccharomyces cere isiae (Sc-Ppm1), Ustilago maydis and Trypanosoma brucei [29] . This hydrophobic terminal domain has been proposed to stabilize these enzymes in membranes [29] . Domain 1 of Mt-Ppm1 is rich in predicted transmembrane segments and may therefore play a similar role in the stabilization of the catalytic domain. In addition, various DPM synthases that possess a C-terminal hydrophobic domain were active in itro when expressed in E. coli. By contrast, human Dpm1, which lacks this hydrophobic domain, is not active in E. coli [29] . In the present study, we show that the second domain of Mt-Ppm1 also lacks the terminal domain but is active in itro when expressed in E. coli. Based on these criteria, Mt-Ppm1 may be considered as the first member of a new class of DPM synthases.
Eukaryotic DPM synthases have been demonstrated to be activated in itro by a cAMP-dependent protein kinase [30, 31] , suggesting that DPM activity is regulated. It is interesting to note that Mt-Ppm1\D2 and its homologues in M. smegmatis and M. leprae possess a conserved serine residue corresponding to the putative phosphorylated serine of various eukaryotic DPM synthases (Figure 1) .
Probable PPM synthases (EC 2.4.1.83) have been identified by homology search in various bacterial genomes (http :\\www. genome.ad.jp\dbget-bin\www.bget ?enzymej2.4.1.83), but to our knowledge Mt-Ppm1 is the first enzyme of this family that has been cloned and studied in bacteria. The identification of the key role of Mt-Ppm1\D1 and Mt-Ppm1\D2 in the synthesis of LAM will help in clarifying the biological importance of such molecules as immunomodulators and drug targets, and in defining pathogenic events and remedies for them. Further
